Phase II trial of the CDK4/6 inhibitor abemaciclib in patients (pts) with advanced and refractory well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP NETs).
Abemaciclib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase II trial of the CDK4/6 inhibitor abemaciclib in patients (pts) with advanced and refractory well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP NETs). ### Output: Abemaciclib